{"nctId":"NCT00118417","briefTitle":"Therapies for Treatment-Resistant Panic Disorder Symptoms","startDateStruct":{"date":"1999-03"},"conditions":["Panic Disorder"],"count":46,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Sertraline","Behavioral: Cognitive behavioral therapy"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Clonazepam","Drug: Sertraline"]}],"interventions":[{"name":"Clonazepam","otherNames":[]},{"name":"Sertraline","otherNames":[]},{"name":"Cognitive behavioral therapy","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of panic disorder\n\nExclusion Criteria:\n\n* History of bipolar disorder, schizophrenia, psychosis, or delusional disorders\n* Post-traumatic stress disorder diagnosis within 6 months prior to study entry\n* Current use of psychotropic medications\n* Current use of cognitive behavioral therapy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Panic Disorder Symptoms, Phase 1 (Week 0 - Week 6)","description":"This measure is the change in points between baseline and endpoint scores on the Panic Disorder Severity Scale (PDSS). The PDSS is a 7-item scale with each item rated from 0 (none) to 4 (extreme), for a total score range of 0 to 28 points, and an established interrater reliability of 0.87.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3","spread":"4.3"}]}]}]},{"type":"PRIMARY","title":"Change in Panic Disorder Symptoms, Phase 2 (Week 6 - Week 12)","description":"This measure is the change in points between baseline and endpoint scores on the Panic Disorder Severity Scale (PDSS). The PDSS is a 7-item scale with each item rated from 0 (none) to 4 (extreme), for a total score range of 0 to 28 points, and an established interrater reliability of 0.87.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.36","spread":"3.44"},{"groupId":"OG001","value":"2.31","spread":"4.29"}]}]}]},{"type":"PRIMARY","title":"Change in Panic Disorder Symptoms, Phase 3 (Week 12 - Week 24)","description":"This measure is the change in points between baseline and endpoint scores on the Panic Disorder Severity Scale (PDSS). The PDSS is a 7-item scale with each item rated from 0 (none) to 4 (extreme), for a total score range of 0 to 28 points, and an established interrater reliability of 0.87.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.78","spread":"3.80"},{"groupId":"OG001","value":"2.9","spread":"3.63"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":39},"commonTop":["Gastrointestinal distress","Headache","Jitteriness or Restlesness","Nausea or Vomiting","Insomnia"]}}}